21820514 33920577 23382880 24366610 21147489 26190541 22683505 34087391 20064390 24302560 20642797 36558920 26269525 25818655 28947113 25991442 22327485 25398949 27199730 29904030 34753687 32129826 30600476 21887328 26153070 20067586 34295920 2450930 - Search Results

Year	Number of Results
2009	7
2010	32
2011	31
2012	17
2013	29
2014	29
2015	21
2016	13
2017	14
2018	20
2019	17
2020	13
2021	18
2022	15
2023	0

1

What have we learned from gene expression profiles in Huntington's disease?

Seredenina T, Luthi-Carter R. Seredenina T, et al. Neurobiol Dis. 2012 Jan;45(1):83-98. doi: 10.1016/j.nbd.2011.07.001. Epub 2011 Jul 12. Neurobiol Dis. 2012. PMID: 21820514 Review.

2

Nucleocytoplasmic Transport: Regulatory Mechanisms and the Implications in Neurodegeneration.

Ding B, Sepehrimanesh M. Ding B, et al. Int J Mol Sci. 2021 Apr 17;22(8):4165. doi: 10.3390/ijms22084165. Int J Mol Sci. 2021. PMID: 33920577 Free PMC article. Review.

3

SUMO-1 modification on K166 of polyQ-expanded ataxin-3 strengthens its stability and increases its cytotoxicity.

Zhou YF, Liao SS, Luo YY, Tang JG, Wang JL, Lei LF, Chi JW, Du J, Jiang H, Xia K, Tang BS, Shen L. Zhou YF, et al. PLoS One. 2013;8(1):e54214. doi: 10.1371/journal.pone.0054214. Epub 2013 Jan 31. PLoS One. 2013. PMID: 23382880 Free PMC article.

4

Treatment of Huntington's disease.

Frank S. Frank S. Neurotherapeutics. 2014 Jan;11(1):153-60. doi: 10.1007/s13311-013-0244-z. Neurotherapeutics. 2014. PMID: 24366610 Free PMC article. Review.

5

The neurology and natural history of patients with indeterminate CAG repeat length mutations of the Huntington disease gene.

Panegyres PK, Goh JG. Panegyres PK, et al. J Neurol Sci. 2011 Feb 15;301(1-2):14-20. doi: 10.1016/j.jns.2010.11.015. Epub 2010 Dec 13. J Neurol Sci. 2011. PMID: 21147489

6

Rhes influences striatal cAMP/PKA-dependent signaling and synaptic plasticity in a gender-sensitive fashion.

Ghiglieri V, Napolitano F, Pelosi B, Schepisi C, Migliarini S, Di Maio A, Pendolino V, Mancini M, Sciamanna G, Vitucci D, Maddaloni G, Giampà C, Errico F, Nisticò R, Pasqualetti M, Picconi B, Usiello A. Ghiglieri V, et al. Sci Rep. 2015 Jul 20;5:10933. doi: 10.1038/srep10933. Sci Rep. 2015. PMID: 26190541 Free PMC article.

7

Striatum specific protein, Rhes regulates AKT pathway.

Bang S, Steenstra C, Kim SF. Bang S, et al. Neurosci Lett. 2012 Jul 19;521(2):142-7. doi: 10.1016/j.neulet.2012.05.073. Epub 2012 Jun 6. Neurosci Lett. 2012. PMID: 22683505 Free PMC article.

8

Nano-ivabradine averts behavioral anomalies in Huntington's disease rat model via modulating Rhes/m-tor pathway.

Saad MA, Ahmed MAE, Elbadawy NN, Abdelkader NF. Saad MA, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2021 Dec 20;111:110368. doi: 10.1016/j.pnpbp.2021.110368. Epub 2021 Jun 1. Prog Neuropsychopharmacol Biol Psychiatry. 2021. PMID: 34087391

9

Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice.

Gu X, Greiner ER, Mishra R, Kodali R, Osmand A, Finkbeiner S, Steffan JS, Thompson LM, Wetzel R, Yang XW. Gu X, et al. Neuron. 2009 Dec 24;64(6):828-40. doi: 10.1016/j.neuron.2009.11.020. Neuron. 2009. PMID: 20064390 Free PMC article.

10

Activators of G protein signaling exhibit broad functionality and define a distinct core signaling triad.

Blumer JB, Lanier SM. Blumer JB, et al. Mol Pharmacol. 2014 Mar;85(3):388-96. doi: 10.1124/mol.113.090068. Epub 2013 Dec 3. Mol Pharmacol. 2014. PMID: 24302560 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results